Literature DB >> 25767625

Unexpected Second Primary Malignancies Detected by F-18 FDG PET/CT During Follow-up for Primary Malignancy: Two Case Reports.

Ji-In Bang1, Eun Seong Lee1, Tae-Sung Kim1, Seok-Ki Kim1.   

Abstract

As the survival rate of cancer patients has increased over the last few decades, the risk of cancer survivors developing second primary malignancies has gained attention. We report two rare cases of second primary hematologic malignancy detected by (18)F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) during follow-up for primary solid malignancies. Acute lymphoblastic leukemia developed in a breast cancer patient and non-Hodgkin lymphoma in an anal cancer patient. F-18 FDG PET/CT findings led to the diagnosis of unexpected second primary hematologic malignancy in cancer survivors in these two cases.

Entities:  

Keywords:  F-18 fluorodeoxyglucose; Hematologic malignancy; Positron emission tomography; Second primary malignancy

Year:  2014        PMID: 25767625      PMCID: PMC4354782          DOI: 10.1007/s13139-014-0302-4

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  17 in total

Review 1.  A tabulated summary of the FDG PET literature.

Authors:  S S Gambhir; J Czernin; J Schwimmer; D H Silverman; R E Coleman; M E Phelps
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

Review 2.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.

Authors:  Johannes Czernin; Martin Allen-Auerbach; Heinrich R Schelbert
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

3.  Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma.

Authors:  Yifan Zhang; Geming Li; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2008-02       Impact factor: 7.794

4.  Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.

Authors:  S M Bakheet; J Powe; A Ezzat; Y Bakri
Journal:  Clin Nucl Med       Date:  1998-09       Impact factor: 7.794

5.  How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?

Authors:  Guohui Wang; Eddie W F Lau; Ramdave Shakher; Danny Rischin; Robert E Ware; Emily Hong; David S Binns; Annette Hogg; Elizabeth Drummond; Rodney J Hicks
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

6.  Therapy-related leukemia and myelodysplasia: susceptibility and incidence.

Authors:  Giuseppe Leone; Livio Pagano; Dina Ben-Yehuda; Maria Teresa Voso
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

Review 7.  Therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2):a case study and review of the literature.

Authors:  Sang-Guk Lee; Jong Rak Choi; Jin Seok Kim; Tae Sung Park; Kyung-A Lee; Jaewoo Song
Journal:  Cancer Genet Cytogenet       Date:  2009-05

Review 8.  Second malignant neoplasms: assessment and strategies for risk reduction.

Authors:  Marie E Wood; Victor Vogel; Andrea Ng; Lewis Foxhall; Pamela Goodwin; Lois B Travis
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Unsuspected second malignancy detection by FDG PET scan.

Authors:  Archi Agrawal; Narendra Nair; Ramesh Agrawal; Nawab S Baghel
Journal:  Clin Nucl Med       Date:  2008-12       Impact factor: 7.794

Review 10.  New 'second primary' cancers.

Authors:  L Feller; J Lemmer
Journal:  SADJ       Date:  2012-05
View more
  2 in total

1.  Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy.

Authors:  Chae Hong Lim; Soo Bin Park; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Yong Chan Ahn; Myung-Ju Ahn; Joon Young Choi
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

2.  Quadruple Multiple Primary Malignancies: Early Detection of Second Primary Malignancy by Esophagogastroduodenoscopy/Colonoscopy Is Crucial for Patients with Classic Kaposi's Sarcoma.

Authors:  Nobuyuki Maruyama; Yuko Okubo; Masato Umikawa; Akiko Matsuzaki; Akira Hokama; Fusahiro Hirano; Tessho Maruyama; Kazuhide Nishihara; Toshiyuki Nakasone; Shoko Makishi; Hiroyuki Nakamura; Naoki Yoshimi
Journal:  Diagnostics (Basel)       Date:  2020-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.